Photo via Gianluca Colla/Bloomberg
This medication is showing promise as both a better chemotherapy medication and one with less side effects.
Chemotherapy robbed Rachel Midgett of her hair, appetite and energy as she battled breast cancer that had spread to her liver. After nine months on Novartis AG (NOVN)’s Afinitor, she ran a half-marathon in Las Vegas in December.
Midgett, 40, is scheduled to have surgery next month to cut the tumor from her liver after undergoing a previous operation to remove her breasts. The procedure could leave her disease- free for the first time since she was diagnosed in 2009.
“I’m a huge fan of Afinitor, it prolonged my life,” Midgett said in a telephone interview from her home in Houston. While on the drug, “I felt like a normal human being again.”